(NASDAQ: ANIX) Anixa Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.35%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.91%.
Anixa Biosciences's earnings in 2026 is -$10,034,000.On average, 7 Wall Street analysts forecast ANIX's earnings for 2026 to be -$11,520,209, with the lowest ANIX earnings forecast at -$12,003,337, and the highest ANIX earnings forecast at -$11,074,507. On average, 7 Wall Street analysts forecast ANIX's earnings for 2027 to be -$12,078,187, with the lowest ANIX earnings forecast at -$12,670,189, and the highest ANIX earnings forecast at -$11,074,507.
In 2028, ANIX is forecast to generate -$13,275,799 in earnings, with the lowest earnings forecast at -$14,003,893 and the highest earnings forecast at -$12,503,476.